Genetics of the epilepsies: Where are we and where are we going?

Current Opinion in Neurology

Volumn 26, Issue 2, 2013, Pages 179-185

  Helbig, Ingo ^a   Lowenstein, Daniel H ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

epilepsy; epileptic encephalopathies; genetics; pharmacogenomics

Indexed keywords

CARBAMAZEPINE; HLA A ANTIGEN; HLA B ANTIGEN; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR ALPHA4BETA2; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3;

ELECTROENCEPHALOGRAM; ENDOPHENOTYPE; EPILEPSY; FEBRILE CONVULSION; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN GENOME PROJECT; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MONOGENIC DISORDER; PHARMACOGENOMICS; REVIEW; RISK FACTOR; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SOMATIC MUTATION; TAIWAN; UNSPECIFIED SIDE EFFECT;

EPILEPSY; HUMANS; RISK;

EID: 84874940821     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32835ee6ff     Document Type: Review

References (43)

1. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
2. Epi4K: gene discovery in 4000 genomes. Epilepsia 2012; 53:1457-1467.
3. Claes L, Ceulemans B, Audenaert D, et al. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 2003; 21:615-621. (Pubitemid 36667351)
4. Harkin LA, McMahon JM, Iona X, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007; 130:843-852. (Pubitemid 46410748)
5. Szepetowski P, Rochette J, Berquin P, et al. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997; 61:889-898. (Pubitemid 27418464)
6. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43:1252-1255.
7. Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012; 90:152-160.
8. Schubert J, Paravidino R, Becker F, et al. PRRT2 mutations are the major cause of benign familial infantile seizures. Hum Mutat 2012; 33:1439-1443.
9. Scheffer IE, Grinton BE, Heron SE, et al. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology 2012; 79:2104-2108.
10. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012; 79:2115-2121.
11. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012; 79:2109-2114.
12. Heron SE, Smith KR, Bahlo M, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012; 44:1188-1190.
13. Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012; 44:1255-1259.
14. Marini C, Guerrini R. The role of the nicotinic acetylcholine receptors in sleeprelated epilepsy. Biochem Pharmacol 2007; 74:1308-1314. (Pubitemid 47417923)
15. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485:242-245.
16. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485:237-241.
17. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43:585-589.
18. Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011; 43:864-868.
19. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367:1921-1929.
20. Veeramah KR, O'Brien JE, Meisler MH, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet 2012; 90:502-510.
21. Saitsu H, Kato M, Koide A, et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann Neurol 2012; 72:298-300.
22. Sherr E, Massive parallel sequencing in epilepsy. In: Berkovic SF, De Jonghe P, editors. 66th Annual Meeting of the American Epilepsy Society. San Diego, CA, USA: AES; 2012.
23. Helbig I. De novo mutations in infantile spasms and Lennox-Gastaut syndrome. In: Helbig I, Krause R, editors. Beyond the ion channel: the channelopathist. Kiel, Germany: EuroEPINOMICS consortium; 2012. EuroEPINOMICS blog.
24. Berkovic SF, Howell RA, Hay DA, et al. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998; 43:435-445. (Pubitemid 28231717)
25. Helbig I, Scheffer IE, Mulley JC, et al. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol 2008; 7:231-245. (Pubitemid 351215982)
26. Mefford HC, Eichler EE. Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet Dev 2009; 19:196-204.
27. Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010; 42:203-209.
28. Girirajan S, Rosenfeld JA, Coe BP, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012; 367:1321-1331.
29. Helbig I, Hodge SE, Ottman R. Familial cosegregation of rare genetic variants with disease in complex disorders. Eur J Hum Genet 2012. [Epub ahead of print]
30. Heinzen EL, Depondt C, Cavalleri GL, et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 2012; 91:293-302.
31. Kasperaviciute D, Catarino CB, Heinzen EL, et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010; 133:2136-2147.
32. Steffens M, Leu C, Ruppert AK, et al. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet 2012; 21:5359-5372.
33. Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B-1502 screening in Taiwan. N Engl J Med 2011; 364:1126-1133.
34. McCormack M, Alfirevic A, Bourgeois S, et al. HLA-A-3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011; 364:1134-1143.
35. Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001; 28:49-52. (Pubitemid 32405816)
36. Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001; 68:859-865. (Pubitemid 32289731)
37. Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na\+-channel beta1 subunit gene SCN1B. Nat Genet 1998; 19:366-370. (Pubitemid 28357909)
38. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645. (Pubitemid 41079594)
39. Neubauer BA, Fiedler B, Himmelein B, et al. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998; 51:1608-1612.
40. de Kovel CG, Pinto D, Tauer U, et al. Whole-genome linkage scan for epilepsy-related photosensitivity: a mega-analysis. Epilepsy Res 2010; 89:286-294.
41. Helbig KL, Bernhardt BA, Conway LJ, et al. Genetic risk perception and reproductive decision making among people with epilepsy. Epilepsia 2010; 51:1874-1877.
42. Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44:941-945.
43. Lindhout D. Somatic mosaicism as a basic epileptogenic mechanism? Brain 2008; 131:900-901. (Pubitemid 351499435)